Listing Amsterdam Molecular Therapeutics Terminates and Company and its Shares Cease to Exist
AMSTERDAM, November 16, 2012 /PRNewswire/ --
Amsterdam Molecular Therapeutics (AMT) Holding NV in liquidation (in liquidatie) (Euronext: AMT) announces that during the action period (verzetsperiode) no action (verzet) was instituted against the account and justification (rekening en verantwoording) as prepared and made available for inspection by the liquidators.
In accordance with previous announcements, as of 19 November 2012, AMT's shares will be delisted from NYSE Euronext in Amsterdam, with 16 November 2012 being the last trading date. On 19 November 2012, AMT's liquidation shall be finalised and the legal entity AMT shall cease to exist. As a consequence of AMT ceasing to exist, all AMT shares shall also cease to exist on 19 November 2012, without any (further) distribution or compensation to their holders. AMT shareholders that hold their AMT shares in book entry form will have their position in AMT shares in their securities account struck and deleted as per 19 November 2012. To the extent that AMT shares still may appear in your securities account after 19 November 2012, this will be for administrative purposes only, as the AMT shares proper shall then no longer exist.
On March 30, 2012, an extraordinary general meeting of shareholders approved a major corporate restructuring and financing transaction involving the disposal of the Group's entire business and operations to uniQure B.V. and the subsequent dissolution, liquidation and delisting of AMT (in liquidation).
SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos and customised feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Until you hear the full story, why would you invest?
Making sound investment decisions can be difficult. You can study the figures and read the analyst recommendations, but how do you really know the story behind company strategy? How can you get answers to your questions?
The Private Investor Network helps you to reach an informed decision on the stocks you pick. Interactive presentations from UK listed companies give you the kind of access previously enjoyed only by the big fund managers. And with keynote speeches from industry experts, downloadable content and an investor lounge where you can swap tips with your peers, you can invest with confidence.
For more information, and to register for FREE, visit us at www.privateinvestornetwork.co.uk
Get content for your website
Enhance your website's or blog's content with PR Newswire's customised real-time news feeds.
Contact PR Newswire
Send us an email at MarketingUK@prnewswire.co.uk or call us at +44 (0)20 7454 5382
Become a PR Newswire client
Request more information about PR Newswire products & services or call us at +44 (0)20 7454 5382